U.S. MedTech Market Entry Program | MedTech Innovator Asia
Organised By
Supported By
U.S. MedTech Market Entry Program | MedTech Innovator Asia
The Market Opportunity

Common U.S. Market Access Barriers and Our Solutions

The U.S. MedTech market is the single largest in the world at 35%–47% global share. The gap between a strong Singaporean medtech company and a successful U.S. market entry is usually not due to a lack of product quality, but rather a lack of access to the right doors.

The Challenge
Our Solution
⚖️
Value Proposition Mismatch

What convinces APAC buyers/investors often doesn't resonate with U.S. payers, providers, or procurement teams.

🎯
Specialized Value Program

A value program focused on bringing out the best value proposition for your company in the U.S. market.

📋
Regulatory Complexity

FDA pathways, reimbursement strategy, and clinical evidence requirements need specialist guidance, not guesswork.

👥
Tailored Mentors, Coaches & Curriculum

Specialized coaching based on needs analysis and more!

💸
Cost of Trial & Error

Learning the U.S. market independently takes 2–3 years and significant capital. Most companies run out of runway first.

🌐
Market Expansion Support

Market expansion workshops, webinars, mentorship and more!

🤝
No Warm Introductions

Cold outreach to U.S. hospital systems, distributors, and investors almost never works.

🔗
Curated Warm Introductions

Warm introductions via arranged meetings.

U.S. MedTech Market Entry Program | MedTech Innovator Asia
The Program

A Step by Step Journey

This four-phase program is designed to move 6 Singaporean medtech companies closer to a real foothold in the U.S. market.

1
Phase 1
April – May 2026
Discovery & Selection

A highly selective process designed to select 6 Singapore-based startups to expand into the U.S. market. With limited spots and significant resources dedicated to each company, the program is designed to provide deep, focused support to the selected cohort.

2
Phase 2
May – June 2026
Market Readiness Preparations & U.S. Mission Trip

Needs assessment and intensive pre-mission preparation to ensure companies make full use of their time during the U.S. Mission Trip, which provides targeted, on-the-ground exposure to key stakeholders, partners, and market opportunities.

3
Phase 3
June 2026 – March 2027
Post-Trip Expansion

The post-trip phase is a critical window to capitalize on connections and introductions made during the mission trip. Each company will also undergo a post-mission check-in to ensure the right coaches are assigned, enabling targeted and effective support.

4
Phase 4
April 2027 – April 2028
Post-Program Support

Market entry is a starting line, not a finish line. Up to 12 months of ongoing support, events, and continued access to networks across APAC & U.S.

U.S. MedTech Market Entry Program | MedTech Innovator Asia
Alumni Outcomes

Proven Impact from the Past Two Editions

600+
Business Introductions

Across the U.S. ecosystem — from strategics to service providers, U.S.-based alumni, and more.

235
Mentorship / Coaching Hours

1:1 coaching sessions with subject matter experts, 1:1 mentorship with successful U.S. founder.

76
Investor Introductions

Warm introductions to U.S.-based MedTech-focused investors, family offices, and venture funds.

Alumni Circles
Investor Pitching
Partner Dinner
Investor Conference
Market Access Workshops
Value Program
Tailored Webinars
U.S. MedTech Market Entry Program | MedTech Innovator Asia

What Participants Say

“

I found out that there are more work to be done, market access strategy, reimbursement strategy, that you'll never get knowledge in Singapore.

✓ U.S. CPT Code & Clinical Trials
Tai Lim Credo Diagnostics — 2024 Cohort
“

I have personally benefited from the tons of very good connections that MTI has made for us. I gained a very good understanding of the reinvestment, the commercialization strategy in the U.S., and that really helped us to pave our way of how we want to tackle this market.

✓ USD 7M Seed+ Round
Adrian Ang Aevice Health — 2024 Cohort
“

The most valuable experience for me will be knowing all the strategies, building the relationship with potential coaches and mentors for my future expansion in the US market.

✓ Incorporated an entity in Delaware, U.S.
Jane Wang Roceso Technologies — 2025 Cohort
U.S. MedTech Market Entry Program | MedTech Innovator Asia
The Investment

Is it worth it? Could you do this independently instead?

Exploring a U.S. market expansion independently costs far more; in time, capital and missed opportunities.

Going Independent
SGD 40,500+
estimated cost if done independently
  • ✗ Coaching ~SGD 30,000
  • ✗ Business matching with prospects: ~SGD 1,500/prospect
  • ✗ Conference & event access fees: ~SGD 5,000
  • ✗ Flights & accommodations (1x trip): ~SGD 4,000
  • ✗ Cold outreach & market intelligence: priceless
  • ✗ Mentorship: priceless
Recommended
With Our Program
SGD 5,000
per company — payment made only upon program acceptance
  • ✓ Coaching and mentorships
  • ✓ Specialized value program
  • ✓ 10+ curated warm business introductions
  • ✓ Guided U.S. Mission Trip (accommodations provided)
  • ✓ Webinars & market expansion workshops
  • ✓ Post-program support
  • Contact us to find out more
U.S. MedTech Market Entry Program | MedTech Innovator Asia
Who Should Apply

Is This Program Right for You?

✓
Incorporated in Singapore
✓
Minimum 30% local shareholding
✓
Medical device, diagnostic, or digital health company
✓
Interest in entering or expanding to the U.S. market
✓
C-Suite commitment to participate in all program phases
U.S. MedTech Market Entry Program | MedTech Innovator Asia
FAQ

Frequently Asked Questions

Everything you need to know before applying.

Introductions are curated specifically to your product category, regulatory stage, and commercial goals. Past cohort companies have received warm introductions to GPOs, FDA regulatory consultants, reimbursement experts, and U.S.-based investors and more.
No — FDA clearance is not required to apply. Many participants join specifically to develop their FDA regulatory strategy as part of the program.
We will be selecting 6 companies for this cohort. Cohort sizes are deliberately limited to ensure every participating company receives meaningful attention and resources.
U.S. MedTech Market Entry Program | MedTech Innovator Asia

Ready to Enter the World's Largest MedTech Market?

Secure your spot now and take advantage of our network to gain valuable mentors, coaches and experts that can help you accelerate your U.S. Market Access journey!

Apply for the Program →

Questions? Contact us at nerissa@medtechinnovator.org